Abiopharma

🔍 GILLIGAN J KEVIN (Director)

Company: GRACO INC (GGG)

Report Date: 2026-07-01

Detailed Transactions and Holdings:

• Acquired 621 shares of Deferred Stock Shares (Derivative)
  Date: 2026-07-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 99,367.07 | transaction_form_type: 4 | Footnotes: F1, F2, F1, F1, F3

Footnotes:

• F1: The deferred stock shares were accrued under the Graco Inc. Amended and Restated 2019 Stock Incentive Plan and are to be settled 100% in Graco common stock in a lump sum or installments upon reporting person's termination of service on the Board.
• F2: Shares of Graco Inc. deferred stock received in lieu of quarterly retainer fees.
• F3: The number of deferred stock shares includes deferred stock shares acquired under the Graco Inc. Automatic Dividend Reinvestment Plan (DRIP), exempt under Rule 16a-11.